Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 210

Results For "C"

9171 News Found

Lonza announces first GMP batch completion at next-generation mammalian manufacturing facility in US
News | November 25, 2024

Lonza announces first GMP batch completion at next-generation mammalian manufacturing facility in US

First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)


Surendralal Karsanbhai elected to Merck Board of Directors
People | November 25, 2024

Surendralal Karsanbhai elected to Merck Board of Directors

With the addition of Karsanbhai, the Merck board will consist of 13 members


Sourav Ganguly launches Beurer India's GL 22 Blood Glucose Monitor
Medical Device | November 25, 2024

Sourav Ganguly launches Beurer India's GL 22 Blood Glucose Monitor

The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs


USFDA accepts Blenrep combinations for treatment of relapsed/refractory multiple myeloma
Drug Approval | November 25, 2024

USFDA accepts Blenrep combinations for treatment of relapsed/refractory multiple myeloma

If approved, Blenrep (belantamab mafodotin) in combinations with BorDex (BVd) and PomDex (BPd) could redefine multiple myeloma treatment at or after first relapse


Amalgamation of Gujarat Themis Biosyn with Themis Medicare
News | November 23, 2024

Amalgamation of Gujarat Themis Biosyn with Themis Medicare

The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL


IMCD expands its Pharmaceuticals Technical Centre in Jakarta
Supply Chain | November 23, 2024

IMCD expands its Pharmaceuticals Technical Centre in Jakarta

The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards


Merck recommends rejection of TRC Capital’s “Mini-Tender” Offer
News | November 23, 2024

Merck recommends rejection of TRC Capital’s “Mini-Tender” Offer

The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024


JHU signs MoU with Ajit Isaac Foundation to bring essential palliative care services to rural India’s terminally ill
Healthcare | November 22, 2024

JHU signs MoU with Ajit Isaac Foundation to bring essential palliative care services to rural India’s terminally ill

The collaboration offers opportunities for training, research fellowships, workshops and conferences at palliative care centers managed by Ajit Isaac Foundation